How elements of the Indian state purchase drugs
Harleen Kaur (),
Ajay Shah () and
Siddhartha Srivastava ()
Additional contact information
Harleen Kaur: Independent Researcher
Siddhartha Srivastava: King's College, London
No 5, Working Papers from xKDR
Quality problems in drug purchasing by Indian state agencies lie at the intersection of the field of drug quality in India and the field of government contracting in India. Improvements in the procedures used by state agencies when buying drugs can improve the working of public health care programs, and potentially also influence drug quality in the private market. The first step towards policy analysis and reform lies in careful description of how drug purchase works at present. In this paper, we describe how some elements of the Indian state buy drugs.
JEL-codes: H51 H57 H83 I18 (search for similar items in EconPapers)
Pages: 22 pages
New Economics Papers: this item is included in nep-isf
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
https://papers.xkdr.org/papers/KSS2021_how_india_drugs_procurement.pdf First version, 2021 (application/pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:anf:wpaper:5
Access Statistics for this paper
More papers in Working Papers from xKDR
Bibliographic data for series maintained by Ami Dagli ().